AdvaMed "small" firms already get user fee "credit":
This article was originally published in Clinica
Executive Summary
In reaction to the proposal to introduce a user fee tax credit in the state of Massachusetts (see Clinica 1107), Stephen Ubl, AdvaMed's executive vice-president for federal government relations, called the plan "interesting", but added that the current user fee programme already gives small companies a break by charging them lower user fees. The law defines small companies as those firms with annual sales of under $30m; this rather liberal definition makes it possible for most of industry to qualify. He asked rhetorically how many "truly small companies" there are that enjoy sales amounting into $30m a year.
You may also be interested in...
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.